Zhuozheng Medical (02677.HK) reported a 10.5% year-on-year increase in first-half net profit to RMB 83.39 million, while the new customer-to-member conversion rate remained at a high level of approximately 74.9%.
Gelong Hui, August 13 | Zhuozheng Medical (02677.HK) announced its interim results. For the six months ended June 30, 2026, the company's revenue was RMB 596 million, a year-on-year increase of 17.0%; net profit was RMB 83.39 million, a year-on-year increase of 10.5%, with basic earnings per share of RMB 1.71. In the first half of 2026, the group achieved revenue of RMB 596 million, a year-on-year increase of 17.0%. Of this, revenue from physical medical services was RMB 550 million, a year-on-year increase of 17.6%; revenue from physical medical services (excluding revenue related to acquired entities
DISTINCT HEALTH: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED JUNE 30, 2026
Distinct Healthcare Sets August Board Meeting to Review Interim Results and Dividend
DISTINCT HEALTH: DATE OF BOARD MEETING
Distinct Healthcare Wins Full Shareholder Backing at 2026 AGM
Zhuozheng Medical (02677) adopts the 2026 Share Incentive Plan.
Zhuozheng Medical (02677) announced that on May 13, 2026, the company adopted the plan (namely, the 2026 Share Award Plan constituted by the rules of the plan, in its current format or as amended from time to time). The plan is solely funded by existing shares and does not involve the issuance of any new shares. The plan will remain valid for a period of ten years from the adoption date, with an upper limit of 1.5 million shares available for awards under the plan. The trustee will purchase shares from the secondary market according to the instructions of the board of directors, in compliance with the Listing Rules and the trust deed, to meet the exercise of awards.
Zhuozheng Medical (02677) reported total revenue of approximately RMB 280-290 million in the first quarter, representing a year-on-year increase of 12% to 16%.
Zhuozheng Medical (02677) announced that in the first quarter of 2026, the company's total revenue amounted to approximately RMB 280-290 million, representing a year-on-year growth of 12% to 16% compared to the same period in 2025. In the first quarter of 2026, revenue from physical medical services (excluding the revenue contribution from Wuhan Shenlong Tianxia, in which the company acquired a majority stake in 2024) was approximately RMB 255-265 million, achieving organic year-on-year growth of 23% to 28%. In the first quarter of 2026, the number of patient visits for physical medical services was approximately 216,000, reflecting a year-on-year increase of approximately 12%.
Zhuo Zheng Medical (02677.HK): Total revenue for the first quarter was RMB 280-290 million, representing a year-on-year increase of 12% to 16%.
Gelonghui, May 14th ─ Zhuozheng Medical (02677.HK) announced that in the first quarter of 2026, the company's total revenue reached approximately RMB 280-290 million, representing a year-on-year increase of 12% to 16% compared to the same period in 2025. In the first quarter of 2026, revenue from physical medical services (excluding the revenue contribution from Wuhan Shenlongtianxia, in which the company acquired a majority stake in 2024) amounted to approximately RMB 255-265 million, achieving organic year-on-year growth of 23% to 28%. In the first quarter of 2026, the number of patient visits for physical medical services was approximately 216,000.
DISTINCT HEALTH: 2025 ANNUAL REPORT
Distinct Healthcare Moves Shareholder Communications Online Under New HKEX Rules
Distinct Healthcare's Profit Rises in 2025
Distinct Healthcare's (HKG:2677) profit attributable to owners rose to 135.1 million yuan for 2025, from 83.8 million yuan a year earlier, according to a Wednesday Hong Kong bourse filing.Earnings
Zhuozheng Healthcare (02677) announced its annual results, with adjusted net profit reaching RMB 25.648 million, representing a year-on-year increase of 139.7%.
Zhuozheng Medical (02677) announced its annual results for the fiscal year ended December 31, 2025. The group reported revenue of RMB 1.065 billion (all amounts in RMB unless otherwise stated), representing an increase of 11.1% year-on-year; net profit of RMB 131 million, marking a 63.8% year-on-year increase; adjusted net profit of RMB 25.648 million, reflecting a 139.7% year-on-year growth; and basic earnings per share of RMB 9.68.
DISTINCT HEALTH: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEARENDED DECEMBER 31, 2025